Daily BriefsJapan

Daily Brief Japan: Mazda Motor, Seven & I Holdings, WA Inc, TSE Tokyo Price Index TOPIX, Daiichi Sankyo, GENOVA , Onward Holdings, IDOM Inc, Takashimaya, Vector Inc and more

In today’s briefing:

  • Japan: Potential Passive Selling in November
  • 7&I Holdings (3382 JP) – Artisan Writes Another Letter – Based on Content, They Should Sell Any Pop
  • Wa Inc (7683 JP) – Equity Offering, and TOPIX Inclusion But Very Lopsided Register
  • Fair for Managers Who Are Protected by Cross-Shareholding and Get Inflated Payout Due to Weak Yen?
  • Daiichi Sankyo (4568 JP) Valuation Update – Are We There Yet?
  • GENOVA (9341 JP): 70% Rally Over the Last Two Months; Here’s Why Outperformance to Continue
  • Onward Goes Young with Wego
  • IDOM Inc (7599 JP): 1H FY02/25 flash update
  • Takashimaya (8233 JP): 1H FY02/25 flash update
  • Vector Inc (6058 JP): 1H FY02/25 flash update


Japan: Potential Passive Selling in November

By Brian Freitas

  • Up to 9 stocks could be deleted from global passive portfolios in November. The deletion will lead to liquidity events where trackers will need to sell multiple days of ADV.
  • There has been a buildup of shorts on nearly all these stocks though the extent of the pre-positioning varies.
  • The increase in shorts is smaller than the estimated passive selling, though there is a fair amount of variability across the names.

7&I Holdings (3382 JP) – Artisan Writes Another Letter – Based on Content, They Should Sell Any Pop

By Travis Lundy

  • Some two weeks after it became apparent Alimentation Couche-Tard (ATD CN) had lobbied a bid in for Seven & I Holdings (3382 JP), Artisan Partners wrote a letter.  
  • It was full of misguided analysis, ungrounded insinuation of a general nature without specifying where they would have a problem. It seemed to be complaint for the sake of complaint.
  • Today another public letter. This time there are a couple of worthwhile suggestions, some accusations of fiduciary impropriety based on no evidence, and an implicit admission they should have sold?

Wa Inc (7683 JP) – Equity Offering, and TOPIX Inclusion But Very Lopsided Register

By Travis Lundy

  • Yesterday WA Inc (7683 JP) announced that on the five year anniversary of its listing in 2019, the stock would move to TSE Prime on 1 November 2024
  • They also announced a secondary offering of 2.86mm shares including greenshoe. That’s 15% of shares out but the offering will double total float. This is almost a re-IPO.
  • This will lead to a TOPIX inclusion on 27 December which will be smaller than the offering. This will be all retail. 

Fair for Managers Who Are Protected by Cross-Shareholding and Get Inflated Payout Due to Weak Yen?

By Aki Matsumoto

  • It’s understandable that compensation is paid for managing a global business and achieving significant growth, but it’s also paid for bloated performance in yen terms due to the weak yen.
  • Employee engagement is very important for value-added products and more money should be spent on human capital. Otherwise, higher profit margins are unlikely to be achieved.
  • The election of directors at AGMs rarely results in rejection of the company’s proposal. Cross-shareholdings should be reduced so that managers whose “employment” is protected by cross-shareholdings don’t receive commensurate compensation.

Daiichi Sankyo (4568 JP) Valuation Update – Are We There Yet?

By Avien Pillay

  • At a 51 NPE, Daiichi Sankyo was priced for perfection.
  • We do like their focus on the high growth oncology segment, however, we felt that the valuation left no room for error.
  • Post the two disappointing trial announcements, at a 39 NPE, the valuation is become more palatable and getting closer to our mid-thirties target entry point.

GENOVA (9341 JP): 70% Rally Over the Last Two Months; Here’s Why Outperformance to Continue

By Tina Banerjee

  • GENOVA (9341 JP) recorded better-than-expected sales and operating profit in Q1FY25, driven by continued strong demand. With the progress achieved in Q1FY25, the company is expected to beat H1FY25 guidance.
  • Medical Platform business has been experiencing steady growth in both the number of articles and page views, leading to creation of multiple contracts and improve the platform’s unit contract price.  
  • The company had 14K customers for the Medical Platform Business and the Smart Clinic Business in Q1FY25, a mere 8% of its estimated potential customer base of 173K clinics.

Onward Goes Young with Wego

By Michael Causton

  • Most of Onward’s current customers are in their 40s and older but the purchase of casual clothing retailer, Wego, increases its exposure to people in their teens and 20s. 
  • It will accelerate development of new omnichannel brands to match as part of plans to grow sales by 50% in the next six years and more than double operating profits.
  • Onward itself has been transformed by a switch to omnichannel and after years of slashing stores and sales now looks set to become a growth business again.

IDOM Inc (7599 JP): 1H FY02/25 flash update

By Shared Research

  • In 1H FY02/25, sales rose JPY46.0bn (22.6%) YoY, driven by large store operations and retail unit sales.
  • Operating profit increased JPY3.0bn (42.1%) YoY, with gross profit per retail unit rising to JPY440,000 (+60,000 YoY).
  • Revised FY02/25 forecast projects sales of JPY500.0bn (+19.1% YoY), operating profit of JPY20.3bn (+26.0% YoY).

Takashimaya (8233 JP): 1H FY02/25 flash update

By Shared Research

  • The company revised its FY02/25 forecast, projecting operating revenue of JPY495.0bn and operating profit of JPY55.0bn.
  • Operating revenue and profit grew YoY across segments, with notable growth in Domestic Department Store and Contract and Design.
  • Takashimaya Financial Partners Co., Ltd. saw increased revenue from card transactions and expanded its Social Lending business.

Vector Inc (6058 JP): 1H FY02/25 flash update

By Shared Research

  • Revenue decreased 4.1% YoY to JPY27.4bn, while operating profit increased 39.5% YoY to JPY2.1bn.
  • PR and Advertising saw significant profit growth due to provisions reversal, while Direct Marketing faced profit decline.
  • Revenue forecast downgraded; 1H revenue fell short due to client loss and food safety impact.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars